These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 16472263)

  • 41. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Referral and consultation in asthma and COPD: an exploration of pulmonologists' views.
    Schermer T; Smeenk F; van Weel C
    Neth J Med; 2003 Mar; 61(3):71-81. PubMed ID: 12765227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis and management of chronic obstructive pulmonary disease].
    Sato N; Kanazawa M
    Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic obstructive pulmonary disease: diagnosis and management.
    Downs CA; Appel SJ
    J Am Acad Nurse Pract; 2007 Mar; 19(3):126-32. PubMed ID: 17341279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence.
    Kainu A; Rouhos A; Sovijärvi A; Lindqvist A; Sarna S; Lundbäck B
    Scand J Public Health; 2013 Aug; 41(6):570-8. PubMed ID: 23599377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
    Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
    Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant bronchodilator responsiveness and "reversibility" in a population sample.
    Prentice HA; Mannino DM; Caldwell GG; Bush HM
    COPD; 2010 Oct; 7(5):323-30. PubMed ID: 20854046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of bronchodilator use on the prevalence of COPD in population-based samples.
    Pérez-Padilla R; Hallal PC; Vázquez-García JC; Muiño A; Máquez M; López MV; de Oca MM; Tálamo C; Valdivia G; Pertuzé J; Jardim J; Menezes AM;
    COPD; 2007 Jun; 4(2):113-20. PubMed ID: 17530504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
    Kałucka S
    Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study.
    Hansen JG; Pedersen L; Overvad K; Omland Ø; Jensen HK; Sørensen HT
    COPD; 2008 Dec; 5(6):347-52. PubMed ID: 19353348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.
    Chavez PC; Shokar NK
    COPD; 2009 Dec; 6(6):446-51. PubMed ID: 19938968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice.
    Hoogendoorn M; Feenstra TL; Schermer TR; Hesselink AE; Rutten-van Mölken MP
    Respir Med; 2006 Jan; 100(1):83-6. PubMed ID: 15894477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic obstructive pulmonary disease and associated health-care resource use - North Carolina, 2007 and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(8):143-6. PubMed ID: 22377845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bronchodilators--effective also in negative broncholysis test. Decreased dyspnea decreased in any case].
    Vogelmeier C
    MMW Fortschr Med; 2002 Apr; 144(15):34-6, 38. PubMed ID: 12004447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.
    Zhang J; Zhou JB; Lin XF; Wang Q; Bai CX; Hong QY
    Respirology; 2013 Feb; 18(2):297-302. PubMed ID: 23051099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Shortness of breath--is it chronic obstructive pulmonary disease?
    McDonald CF
    Aust Fam Physician; 2005 Jul; 34(7):541-5. PubMed ID: 15999164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.